Large Neuronetics (STIM) holder discloses 6,985,404-share position
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Neuronetics, Inc. reported that significant shareholder Jorey Chernett beneficially owns 6,985,404 shares of the company’s common stock. This Form 3 filing is an initial statement of holdings by a more than ten percent owner and does not reflect any new share transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Chernett Jorey
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock, $0.01 Par Value | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 Par Value — 6,985,404 shares (Direct)
Footnotes (1)
FAQ
What does Jorey Chernett’s Form 3 filing for Neuronetics (STIM) show?
The Form 3 shows that Jorey Chernett beneficially owns 6,985,404 shares of Neuronetics common stock. This is an initial ownership report as a more than ten percent holder, rather than a record of recent share purchases or sales.
Is Jorey Chernett a director or officer of Neuronetics (STIM)?
According to the filing, Jorey Chernett is not a director or officer of Neuronetics. The person is classified instead as a more than ten percent owner, based on their reported beneficial ownership of 6,985,404 common shares.
Does the Neuronetics (STIM) Form 3 indicate any recent insider trades?
The Form 3 does not indicate any recent insider trades. It records an initial holding entry with 6,985,404 shares and a transaction type of “holding,” meaning the focus is on disclosing existing ownership rather than documenting new buy or sell activity.
Why is Jorey Chernett required to file a Form 3 for Neuronetics (STIM)?
A Form 3 is required when someone becomes a more than ten percent beneficial owner of a company’s equity securities. Jorey Chernett’s reported 6,985,404 Neuronetics shares trigger this disclosure obligation as a significant holder under SEC rules.